Cargando…
Marine Antitumor Drugs: Status, Shortfalls and Strategies
Cancer is considered as one of the deadliest diseases in the medical field. Apart from the preventive therapies, it is important to find a curative measure which holds no loopholes and acts accurately and precisely to curb cancer. Over the past few decades, there have been advances in this field and...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993001/ https://www.ncbi.nlm.nih.gov/pubmed/21116415 http://dx.doi.org/10.3390/md8102702 |
_version_ | 1782192798550720512 |
---|---|
author | Bhatnagar, Ira Kim, Se-Kwon |
author_facet | Bhatnagar, Ira Kim, Se-Kwon |
author_sort | Bhatnagar, Ira |
collection | PubMed |
description | Cancer is considered as one of the deadliest diseases in the medical field. Apart from the preventive therapies, it is important to find a curative measure which holds no loopholes and acts accurately and precisely to curb cancer. Over the past few decades, there have been advances in this field and there are many antitumor compounds available on the market, which are of natural as well as synthetic origin. Marine chemotherapy is well recognized nowadays and profound development has been achieved by researchers to deal with different molecular pathways of tumors. However, the marine environment has been less explored for the production of safe and novel antitumor compounds. The reason is a number of shortfalls in this field. Though ample reviews cover the importance and applications of various anticancerous compounds from marine natural products, in the present review, we have tried to bring the current status of antitumor research based on marine inhibitors of cancer signaling pathways. In addition, focus has been placed on the shortfalls and probable strategies in the arena of marine antitumor drug discovery. |
format | Text |
id | pubmed-2993001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Molecular Diversity Preservation International |
record_format | MEDLINE/PubMed |
spelling | pubmed-29930012010-11-29 Marine Antitumor Drugs: Status, Shortfalls and Strategies Bhatnagar, Ira Kim, Se-Kwon Mar Drugs Review Cancer is considered as one of the deadliest diseases in the medical field. Apart from the preventive therapies, it is important to find a curative measure which holds no loopholes and acts accurately and precisely to curb cancer. Over the past few decades, there have been advances in this field and there are many antitumor compounds available on the market, which are of natural as well as synthetic origin. Marine chemotherapy is well recognized nowadays and profound development has been achieved by researchers to deal with different molecular pathways of tumors. However, the marine environment has been less explored for the production of safe and novel antitumor compounds. The reason is a number of shortfalls in this field. Though ample reviews cover the importance and applications of various anticancerous compounds from marine natural products, in the present review, we have tried to bring the current status of antitumor research based on marine inhibitors of cancer signaling pathways. In addition, focus has been placed on the shortfalls and probable strategies in the arena of marine antitumor drug discovery. Molecular Diversity Preservation International 2010-10-15 /pmc/articles/PMC2993001/ /pubmed/21116415 http://dx.doi.org/10.3390/md8102702 Text en © 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Bhatnagar, Ira Kim, Se-Kwon Marine Antitumor Drugs: Status, Shortfalls and Strategies |
title | Marine Antitumor Drugs: Status, Shortfalls and Strategies |
title_full | Marine Antitumor Drugs: Status, Shortfalls and Strategies |
title_fullStr | Marine Antitumor Drugs: Status, Shortfalls and Strategies |
title_full_unstemmed | Marine Antitumor Drugs: Status, Shortfalls and Strategies |
title_short | Marine Antitumor Drugs: Status, Shortfalls and Strategies |
title_sort | marine antitumor drugs: status, shortfalls and strategies |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993001/ https://www.ncbi.nlm.nih.gov/pubmed/21116415 http://dx.doi.org/10.3390/md8102702 |
work_keys_str_mv | AT bhatnagarira marineantitumordrugsstatusshortfallsandstrategies AT kimsekwon marineantitumordrugsstatusshortfallsandstrategies |